Molecular genetic tests use DNA or RNA as the analyte of interest. The type of sample required is usually whole blood or buccal cells. Certain tests require specific tissue because RNA is not ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Myriad Genetics (MYGN) and Lumea have signed an agreement to integrate Myriad’s advanced molecular diagnostic tests – Prolaris Prostate Cancer ...

Myriad Genetics and Lumea Inc. partner to integrate ... This integration aims to enhance the efficiency of ordering and delivering molecular tests, allowing healthcare providers to electronically ...

About Precise Molecular Residual Disease (MRD ... Myriad Genetics develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, ...